Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

[18F]PSMA-1007 PET CT in patients with newly-diagnosed prostate cancer Recruiting

2023-504026-19-01 Prostate Cancer 5 2024-06-05
A Phase 1b/2 Study of JNJ-90014496 in Adult Participants with B-cell Non-Hodgkin Lymphoma Recruiting

2023-506267-33-00 Non-Hodgkin Lymphoid Malignancies 3 2024-05-29
Kidney cancer Recruiting

2023-505605-16-00 Metastatic Clear Cell Renal Cell Carcinoma (ccRCC) or p 7 2024-04-24
A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced … Recruiting

2023-503221-19-00 Advanced Non-Small Cell Lung Cancer 4 2024-04-18
A phase I, multicentre, open-label, dose escalation study to determine the safety and preliminary efficacy of MBS8(1V270) administered intra… Recruiting

2024-512294-26-00 Advanced solid tumors 1 2024-04-10
CAR-T-cell treatment for untreated high risk MANtle Cell Lymphoma Recruiting

2022-502405-15-01 Mantle Cell Lymphoma (MCL) 4 2024-04-08
A multi-center, open-label, phase 2 study of Elranatamab in patients with high-risk smoldering multiple myeloma Recruiting

2023-505775-70-00 High risk smoldering multiple myeloma 4 2024-04-08
A randomized phase III trial assessing iberdomide versus iberdomide plus isatuximab maintenance therapy post autologous hematopoietic stem-c… Recruiting

2023-507402-13-00 Multiple myeloma 5 2024-04-03
A phase 1 trial to study how safe and tolerable Lunresertib is, alone or in Combination with RP-3500 or Debio 0123, when administered in pat… Recruiting

2023-510063-35-00 Advanced solid tumors harboring either CCNE1 amplificat 1 2024-03-13
A Phase 1 Study of JNJ-87189401 Combined with JNJ-78278343 for Advanced Prostate Cancer Recruiting

2023-504063-17-00 Advanced Prostate Cancer 1 2024-03-08
A Phase 1 Study of JNJ-87801493 in Combination with CD3 T-Cell Engagers Recruiting

2023-505165-93-00 Non-Hodgkin Lymphoid Malignancies 1 2024-03-01
Study to assess the safety and efficacy of the SpectraCure P18 System Recruiting

2022-502285-24-00 Recurrent prostate cancer 7 2024-03-01
Trial of Two Adagrasib Dosing Regimens in NSCLC with KRAS G12C Mutation Recruiting

2023-503523-25-00 Non-small cell lung cancer 4 2024-02-29
A First-in-Human Study of ABBV-525 (MALT1 Inhibitor) in B-Cell Malignancies Recruiting

2022-503136-13-00 various B-cell malignancies 1 2024-02-29
Mirvetuximab soravtansine in combination with bevacizumab for the maintenance treatment of adult patients with FRα-high recurrent platinum-s… Recruiting

2022-501606-35-01 Platinum-sensitive epithelial ovarian, fallopian tube, 11 2024-02-21
A Study of Repotrectinib versus Crizotinib in Participants with Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-po… Recruiting

2023-505604-32-00 Non small cell lung cancer (NSCLC) 5 2024-01-24
A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III N… Recruiting

2023-503920-14-00 Non-Small Cell Lung Cancer (NSCLC) 5 2024-01-02
CHIP-AML22/Quizartinib sub-study: study of the safety and efficacy of quizartinib in children and adolescents with FLT3-ITD positive AML wit… Recruiting

2023-505000-27-01 newly diagnosed pediatric FLT3-ITD positive and NPM1 wi 4 2023-12-29
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 Trial Recruiting

2022-501551-90-00 Prostate cancer 10 2023-12-13
Study to evaluate the safety, tolerability, maximum tolerated dose and clinical activity of TNB-383B when given to patients with multiple my… Recruiting

2023-506993-11-00 Relapsed or refractory multiple myeloma 1 2023-11-23
Study assessing the efficacy of etoposide free chemotherapy plus durvalumab in first line extensive disease Small Cell Lung Cancer Recruiting

2023-504670-38-00 Extensive disease Small Cell Lung Cancer 4 2023-11-17
Prospective phase I/II trial of an individualized peptide vaccine in pediatric and AYA patients with metastasized fusion-driven sarcomas fol… Recruiting

2024-511337-35-00 The trial will include patients with so called "fusion- 4 2023-11-16
A Study of Ripretinib vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumor (GIST) with Specific KIT Exon Mutations Who Were… Recruiting

2022-503058-37-00 Advanced Gastrointestinal Stromal Tumor 5 2023-11-10
VB10.16 Plus Pembrolizumab in First Line r/m HNSCC Recruiting

2022-503055-26-00 Unresectable recurrent or metastatic HPV16 (Human Papil 9 2023-10-30